论文部分内容阅读
中医热兴起的同时,络病却甚少人知。自上世纪80年代,以岭药业创始人吴以岭院士开始了中医络病理论及其应用研究,这是在我国中医发展史上首次形成的络病理论。“先遣部队”奠基新药研发在吴以岭的指导下,北京以岭药业有限公司小复方创新中药活性成分及天然药物的生物活性研究创新工作室成立了。其领军人为具有丰富的一线研发和项目管理经验的梁俊清博士。“新药研发依靠多学科合作,只有多部门共同努力才能推动药物开发的进程,而我们只是站在了这项工
The rise of Chinese medicine at the same time, the network disease is poorly understood. Since the 80s of last century, Yiling Pharmaceutical founder Wu Yiling began his theory of collateral disease and its application, which is the first theory of collateral disease in the history of Chinese medicine. Pioneering Force Puts Foundation for New Drug R & D Under the guidance of Wu Yiling, Beijing Yiling Pharmaceutical Co., Ltd. established a small innovative research and innovation activity of traditional Chinese medicine active ingredients and natural medicines. Its leader is Dr Leung Chun-ching with extensive experience in frontline R & D and project management. ”Relying on multidisciplinary cooperation in research and development of new drugs, we can only promote the progress of drug development through joint efforts of many departments,